Two Sigma Investments’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-500,000
Closed -$5.4M 3343
2023
Q3
$5.4M Hold
500,000
0.01% 864
2023
Q2
$5.33M Hold
500,000
0.01% 900
2023
Q1
$5.25M Hold
500,000
0.02% 879
2022
Q4
$5.13M Hold
500,000
0.02% 842
2022
Q3
$5M Buy
+500,000
New +$5.01M 0.02% 756

Other funds holding RENE

Two Sigma Investments's RENE Position: Q4 2023 in Review

Two Sigma Investments sold out of Cartesian Growth Corp II (RENE) in Q4 2023, closing a stake of 500,000 shares — an estimated $5.4M sold.

Two Sigma Investments first reported a position in RENE in Q3 2022 and held it in 5 quarters. The position peaked at $5.4M in Q3 2023. 34 funds tracked by Wall St. Rank hold RENE as of Q4 2023.

  • Two Sigma Investments reported no remaining Cartesian Growth Corp II position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Investments sold 500,000 Cartesian Growth Corp II shares in Q4 2023, an estimated $5.4M.
  • Two Sigma Investments first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 5 quarters.
  • Two Sigma Investments's Cartesian Growth Corp II position peaked at $5.4M in Q3 2023.
  • 34 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.